Product Line Growth:
Feedback suggests newer offerings like Pharma Direct and subscriptions are expanding rapidly, indicating momentum beyond the legacy prescription-discount model.
Strategic Partnerships:
Feedback suggests deepening relationships with pharmaceutical manufacturers are driving strong growth in Pharma Direct and expanding medication-access programs.
Healthy Cash Flow:
Feedback suggests operating cash flow was strong in recent periods, even as total revenue was near flat and segment performance was mixed.
